Sucralfate Tablet
Product Images NDC 70771-1833

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sucralfate (NDC 70771-1833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (D11a3885 80a2 410a 959c 9f71ad56d4b3 01)

Figure (D11a3885 80a2 410a 959c 9f71ad56d4b3 01)
Chemical structure diagram of Sucralfate showing its molecular components with notation for aluminum hydroxide and water content variables (x and y). The structure includes R group labeled as SO3Al(OH)2.*
FDA Label Image

Image (D11a3885 80a2 410a 959c 9f71ad56d4b3 02)

Image (D11a3885 80a2 410a 959c 9f71ad56d4b3 02)
Label for Sucralfate Tablets, USP 1 gram oral tablets. The package contains 100 tablets, with NDC 70771-1833-1. The label includes barcode, manufacturer Cadila Healthcare Ltd., Ahmedabad, India, and storage instructions. The label also states the product is Rx only and child-resistant packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.